These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy. Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117 [TBL] [Abstract][Full Text] [Related]
29. The natural history of renal function following orthotopic heart transplant. Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562 [TBL] [Abstract][Full Text] [Related]
30. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression. Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704 [TBL] [Abstract][Full Text] [Related]
32. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil. Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175 [TBL] [Abstract][Full Text] [Related]
33. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of thalidomide as immunosuppressor in heterotopic heart transplantation. de Carvalho JB; Petroianu A; Alberti LR Chirurgia (Bucur); 2008; 103(4):429-34. PubMed ID: 18780616 [TBL] [Abstract][Full Text] [Related]
35. The use of ciclosporin in psoriasis. Berth-Jones J J Dermatolog Treat; 2005; 16(5-6):258-77. PubMed ID: 16428145 [TBL] [Abstract][Full Text] [Related]
36. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral. Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation. Wacke R; Kundt G; Gock M; Klar E; Drewelow B; Schareck W Transplant Proc; 2006 Apr; 38(3):751-2. PubMed ID: 16647462 [TBL] [Abstract][Full Text] [Related]
38. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem]. Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339 [No Abstract] [Full Text] [Related]
39. Effects of long-term cyclosporine A therapy on renal functions in Behçet's disease. Saricaoglu H; Bulbul EB; Cikman ST; Dilek K; Tunali S Int J Tissue React; 2004; 26(3-4):93-6. PubMed ID: 15648441 [TBL] [Abstract][Full Text] [Related]
40. [Monitoring and secondary effects of immunosuppressants in the transplant]. Sádaba B An Sist Sanit Navar; 2006; 29 Suppl 2():207-18. PubMed ID: 16998527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]